SCHEMBL6116644

SCHEMBL6116644

CCCCCCC(C(=O)OCC)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HSPD1 P10809 1/20 0.41
BLM P54132 1/20 0.41
HSPE1 P61604 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.41
FAAH O00519 7/20 0.40
CES1 P23141 5/20 0.40
GPR84 Q9NQS5 3/20 0.40
CES2 O00748 3/20 0.40
CYP1A2 P05177 1/20 0.40
FFAR1 O14842 1/20 0.40
CPB2 Q96IY4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6117365 1.00 ZDHHC7 (0.43) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6116587 1.00 ZDHHC7 (0.43) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6117216 0.98 USP2 (0.41) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6115966 0.93 CA2 (0.44) USP2LMNAMEN1KMT2AHSD17B10
SCHEMBL6117183 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6116913 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6116559 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6117136 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6117008 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1
SCHEMBL6117225 0.88 MAPT (0.46) ZDHHC7USP2LMNAMAPTHSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2460802-B1 TRIFLUOROMETHYLTHIOPHENIUM DERIVATIVE SALTS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF TRIFLUOROMETHYL-CONTAINING COMPOUNDS USING SAME NAGOYA INST TECHNOLOGY (JP) 2014-09-03 EP disclosed
US-8703969-B2 Trifluoromethylthiophenium derivative salt, method for producing the same, and method for producing trifluoromethyl-containing compounds using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2014-04-22 US disclosed
US-20120130090-A1 TRIFLUOROMETHYLTHIOPHENIUM DERIVATIVE SALT, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING TRIFLUOROMETHYL-CONTAINING COMPOUNDS USING THE SAME TOSOH F-TECH, INC. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130090-A1 TRIFLUOROMETHYLTHIOPHENIUM DERIVATIVE SALT, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING TRIFLUOROMETHYL-CONTAINING COMPOUNDS USING THE SAME TST, CBR3, CYP4B1 ZDHHC7 1211/4885USP2 4219/4885LMNA 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.